Both medications are FDA-approved treatments, and your healthcare provider can guide you on which is suitable for your condition
Tirzepatide, on the other hand, is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist
Patients uncertain about appropriate site selection should consult their healthcare provider or diabetes educator for personalized guidance
They are not interchangeable, and the choice depends on symptoms, blood results, and clinical judgement
Studies have suggested that exposure to the peptide even nine hours after the induction of a stroke model may help mitigate brain cell damage and cell death, as well as support parameters of learning and memory in research models
Effects of high-protein diet on glycemic control, insulin resistance and blood pressure in type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials